Market News AIOpen the app

Barclays increased its price target for Medline Inc. from $43 to $45.

OpinionRead the original at moomoo.com
Good for MDLN

Barclays raised its Medline share-price target, showing a more favorable view of the shares. The story reports no change in Medline's sales or profit, so the positive signal is limited.

MDLN · Medline Industries, Inc.

AI read · Good for MDLN

The AI's read

This is Barclays' view of what Medline shares could be worth, not a report of changed sales or profit. The notice also says it is not an investment recommendation, so the signal is limited, but the higher target leans favorable.

Get alerts for MDLN

Follow Medline Industries, Inc. (MDLN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MDLN
Free on the App Store and Google Play, or on the web.